Advances in genomics, clinical diagnostic methods, and therapies are now transforming healthcare. By integrating clinical data with genetic information, healthcare providers can enhance population screening, diagnosis, prognosis, and risk management. In some cases, these advancements enable the development of innovative, targeted therapies for conditions such as cardiovascular diseases, lipid disorders, diabetes, and cancer, as well as other clinically complex morbidities.
The Harvard Medical School International Center for Genetic Disease (HMS-iCGD) has been established as a collaborative platform dedicated to the investigation of genetic diseases across diverse populations.
The mission of the Harvard Medical School International Center for Genetic Disease (HMS-iCGD) is to advance genomic medicine research through strategic partnerships with governments, academia, and industry, with the ultimate goal of improving public health and patient outcomes. The HMS-iCGD brings together clinicians, scientists, and patients from across the globe to uncover the genetic causes of diseases and translate these discoveries into improved diagnostics, innovative treatments, and effective prevention strategies.
The scientists at HMS-iCGD work collaboratively to drive advancements that are shaping the future of precision and genomic medicine.
To conduct genetic research focused on the causes, prevention, and potential treatment of diseases through the analysis of patients and healthy individuals from diverse countries. To enable the clinical implementation of genomic medicine worldwide through capacity-building initiatives. To enhance genomics research collaborations between HMS-affiliated institutions and institutions worldwide..